Similar articles

• Pilot study--cimetidine enhances lymphocyte infiltration of human colorectal carcinoma: results of a small randomized control trial.

  Adams WJ, Morris DL. Adams WJ, et al. Cancer. 1997 Jul 1;80(1):15-21. doi: 10.1002/(sici)1097-0142(19970701)80:1<15::aid-cncr3>3.0.co;2-e. Cancer. 1997. PMID: 9210704 Clinical Trial.
• Randomized trial of preoperative cimetidine in patients with colorectal carcinoma with quantitative assessment of tumor-associated lymphocytes.

  Kelly MD, King J, Cherian M, Dwerryhouse SJ, Finlay IG, Adams WJ, King DW, Lubowski DZ, Morris DL. Kelly MD, et al. Cancer. 1999 Apr 15;85(8):1658-63. doi: 10.1002/(sici)1097-0142(19990415)85:8<1658::aid-cncr3>3.0.co;2-q. Cancer. 1999. PMID: 10223557 Clinical Trial.
• Cimetidine and colorectal cancer--old drug, new use?

  Morris DL, Adams WJ. Morris DL, et al. Nat Med. 1995 Dec;1(12):1243-4. doi: 10.1038/nm1295-1243. Nat Med. 1995. PMID: 7489398 No abstract available.
• Cimetidine in colorectal cancer--are the effects immunological or adhesion-mediated?

  Eaton D, Hawkins RE. Eaton D, et al. Br J Cancer. 2002 Jan 21;86(2):159-60. doi: 10.1038/sj.bjc.6600097. Br J Cancer. 2002. PMID: 11870499 Free PMC article.
• Cimetidine: an anticancer drug?

  Kubecova M, Kolostova K, Pinterova D, Kacprzak G, Bobek V. Kubecova M, et al. Eur J Pharm Sci. 2011 Apr 18;42(5):439-44. doi: 10.1016/j.ejps.2011.02.004. Epub 2011 Feb 15. Eur J Pharm Sci. 2011. PMID: 21329756 Review.